India will begin vaccination against the deadly coronavirus tomorrow, with frontline health workers receiving the first shots. Vaccines have been deployed in 12 cities for the first phase of the campaign and placed under armed guard. States have been allocated vaccine supplements based on data from their health workers.
The country’s drug regulator has approved two vaccines for emergency use – Kovishield of Oxford AstraZeneca and Kovaxin of indigenously developed India Biotech. Both are two-dose vaccines that have to be set aside for 28 days.
The vaccination campaign will use an online digital platform developed by the Ministry of Health Co-Win to facilitate real-time information on vaccine stocks, storage temperatures, and tracking of vaccine recipients. The Center has also set up a 24×7 hotline – 1075 to address questions related to the vaccine rollout.
As India prepares to launch the Kovid-19 vaccination campaign tomorrow, here is a fact file on the vaccine:
- Pregnant women and lactating mothers should not administer shots
- Jabs should not be given to people with a history of anaphylactic or allergic reactions
- Vaccine supplements will not be given to people allergic to injectable therapy, pharma products, etc.
- Special caution should be taken in patients with clotting or coagulation disorders
- Vaccine specific contraindications (the condition or factor that serves as a reason for stopping a certain medical treatment) may apply when new information is available